CDIVX
Price
$12.29
Change
+$0.09 (+0.74%)
Updated
Jun 6 closing price
Net Assets
30.22M
VIMAX
Price
$339.42
Change
+$2.43 (+0.72%)
Updated
Jun 6 closing price
Net Assets
185.28B
Interact to see
Advertisement

CDIVX vs VIMAX

Header iconCDIVX vs VIMAX Comparison
Open Charts CDIVX vs VIMAXBanner chart's image
Copeland Dividend Growth Fund
Price$12.29
Change+$0.09 (+0.74%)
VolumeN/A
Net Assets30.22M
Vanguard Mid Cap Index Admiral
Price$339.42
Change+$2.43 (+0.72%)
VolumeN/A
Net Assets185.28B
CDIVX vs VIMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CDIVX vs. VIMAX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDIVX is a Buy and VIMAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 185B vs. CDIVX (30.2M). VIMAX pays higher dividends than CDIVX: VIMAX (1.52) vs CDIVX (0.27). CDIVX was incepted earlier than VIMAX: CDIVX (12 years) vs VIMAX (24 years). CDIVX (1.99) is less costly to investors than VIMAX (0.05). CDIVX is a more actively managed with annual turnover of: 32.00 vs. VIMAX (16.00). VIMAX has a lower initial minimum investment than CDIVX: VIMAX (3000) vs CDIVX (25000). VIMAX annual gain was more profitable for investors over the last year : 12.17 vs. CDIVX (-5.25). VIMAX return over 5 years is better than : 59.65 vs. CDIVX (16.95).
CDIVXVIMAXCDIVX / VIMAX
Total Expense Ratio1.050.052,100%
Annual Report Gross Expense Ratio1.990.053,980%
Fund Existence12 years24 years-
Gain YTD1.1613.16137%
Front LoadN/AN/A-
Min. Initial Investment250003000833%
Min. Initial Investment IRAN/AN/A-
Net Assets30.2M185B0%
Annual Yield % from dividends0.271.5218%
Returns for 1 year-5.2512.17-43%
Returns for 3 years1.9123.758%
Returns for 5 years16.9559.6528%
Returns for 10 years-13.69116.84-12%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LOGSX20.56N/A
N/A
Live Oak Health Sciences
OEQIX8.34N/A
N/A
Oaktree Emerging Markets Equity I
POVSX29.69N/A
N/A
Putnam International Equity A
ABYSX20.41N/A
N/A
AB Discovery Value Advisor
AKREX69.19N/A
N/A
Akre Focus Retail